stockrowBioventus Inc.
BVS Healthcare Medical Devices
Bioventus Inc.’s revenue for fiscal 2025 (year ended December 2025) was $568.1 million, down 0.91% from fiscal 2024.
- Revenue
- +2.73%
- EPS
- +100.6%
- Free cash flow
- −31.4%
- Total debt
- −28.8%
Quarter to September 2026, against a year earlier
Follow BVS
Alert me
Bioventus Inc. (BVS) EV/Sales
As of 5 November 2026, Bioventus Inc. (BVS) trades at a EV/Sales of 1.6×. Over the past ten years it has ranged from 0.5× (March 2021) to 2.6× (June 2021); the current reading is higher than 56% of that period. That is below the Medical Devices industry median of 2.7× and below the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.3× | (23.32%) |
| FY2024 | 1.7× | 26.45% |
| FY2023 | 1.3× | 25.25% |
| FY2022 | 1.1× | (52.33%) |
| FY2021 | 2.2× | 268.46% |
| FY2020 | 0.6× | 0.00% |
| FY2019 | 0.6× | 0.00% |
| FY2018 | 0.6× | 0.00% |
| FY2017 | 0.6× | 0.00% |
| FY2016 | 0.6× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2026 | 1.9× | 30.72% |
| Jun 2026 | 1.5× | 0.10% |
| Mar 2026 | 1.5× | 13.56% |
| Dec 2025 | 1.3× | 0.65% |
| 24 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| INMD InMode Ltd. compare | 0.8× |
| AHCO AdaptHealth Corp. compare | 0.8× |
| QDEL QuidelOrtho Corporation compare | 1.4× |
| BVS Bioventus Inc. | 1.6× |
| KIDS OrthoPediatrics Corp. compare | 3.1× |
| BBNX Beta Bionics, Inc. compare | 3.8× |
| SIBN SiBone compare | 4.4× |
| CBLL CeriBell, Inc. compare | 8.3× |
| IRMD iRadimed Corporation compare | 11.4× |
| Medical Devices industry median | 2.7× |
| Healthcare sector median | 3.5× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)